BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 29194599)

  • 41. Application of a validated LC-MS/MS method for JWH-073 and its metabolites in blood and urine in real forensic cases.
    Ozturk S; Ozturk YE; Yeter O; Alpertunga B
    Forensic Sci Int; 2015 Dec; 257():165-171. PubMed ID: 26360591
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Urinary prevalence, metabolite detection rates, temporal patterns and evaluation of suitable LC-MS/MS targets to document synthetic cannabinoid intake in US military urine specimens.
    Wohlfarth A; Scheidweiler KB; Castaneto M; Gandhi AS; Desrosiers NA; Klette KL; Martin TM; Huestis MA
    Clin Chem Lab Med; 2015 Feb; 53(3):423-34. PubMed ID: 25263309
    [TBL] [Abstract][Full Text] [Related]  

  • 43. LC-QTOF-MS as a superior strategy to immunoassay for the comprehensive analysis of synthetic cannabinoids in urine.
    Kronstrand R; Brinkhagen L; Birath-Karlsson C; Roman M; Josefsson M
    Anal Bioanal Chem; 2014 Jun; 406(15):3599-609. PubMed ID: 24424965
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Driving under the influence of synthetic cannabinoid receptor agonist XLR-11.
    Lemos NP
    J Forensic Sci; 2014 Nov; 59(6):1679-83. PubMed ID: 25088081
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Death after use of the synthetic cannabinoid 5F-AMB.
    Shanks KG; Behonick GS
    Forensic Sci Int; 2016 May; 262():e21-4. PubMed ID: 27017174
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acute intoxication caused by synthetic cannabinoids 5F-ADB and MMB-2201: A case series.
    Barceló B; Pichini S; López-Corominas V; Gomila I; Yates C; Busardò FP; Pellegrini M
    Forensic Sci Int; 2017 Apr; 273():e10-e14. PubMed ID: 28190538
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthetic cannabinoids: Variety is definitely not the spice of life.
    Langford AM; Bolton JR
    J Forensic Leg Med; 2018 Oct; 59():36-38. PubMed ID: 30130700
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Death cases involving certain new psychoactive substances: A review of the literature.
    Kraemer M; Boehmer A; Madea B; Maas A
    Forensic Sci Int; 2019 May; 298():186-267. PubMed ID: 30925344
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aspects related to analysis and medico-legal assessment in the context of the presence of synthetic cannabinoids in biological material based on the example of AB-CHMINACA.
    Romańczuk A; Rojek S; Kula K; Kłys M
    Arch Med Sadowej Kryminol; 2018; 68(4):266-280. PubMed ID: 31025844
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intoxication from the novel synthetic cannabinoids AB-PINACA and ADB-PINACA: A case series and review of the literature.
    Armenian P; Darracq M; Gevorkyan J; Clark S; Kaye B; Brandehoff NP
    Neuropharmacology; 2018 May; 134(Pt A):82-91. PubMed ID: 29037744
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification and quantification of synthetic cannabinoids in "spice-like" herbal mixtures: Update of the German situation for the spring of 2016.
    Langer N; Lindigkeit R; Schiebel HM; Papke U; Ernst L; Beuerle T
    Forensic Sci Int; 2016 Dec; 269():31-41. PubMed ID: 27863282
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthetic cannabinoids: the dangers of spicing it up.
    Salani DA; Zdanowicz MM
    J Psychosoc Nurs Ment Health Serv; 2015 May; 53(5):36-43. PubMed ID: 25974923
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Determination of 22 synthetic cannabinoids in human hair by liquid chromatography-tandem mass spectrometry.
    Hutter M; Kneisel S; Auwärter V; Neukamm MA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Aug; 903():95-101. PubMed ID: 22835826
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Colorimetric Determination of (Aminoalkyl)indole-containing Synthetic Cannabimimetics.
    Durmus H; Durmazel S; Üzer A; Gökdere B; Erçag E; Apak R
    Anal Sci; 2018 Dec; 34(12):1419-1425. PubMed ID: 30197385
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Cannabinoid and cathinone designer drugs - the workings and selected methods of analysis].
    Nędza J; Polaniak R; Bułdak RJ; Majchrzak M; Margasiń-Ska J; Rojkiewicz M; Celiński R; Grochowska-Niedworok E
    Pol Merkur Lekarski; 2016 Jul; 41(241):56-59. PubMed ID: 27734824
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Qualitative Analysis and Detection of the Pyrolytic Products of JWH-018 and 11 Additional Synthetic Cannabinoids in the Presence of Common Herbal Smoking Substrates.
    Raso S; Bell S
    J Anal Toxicol; 2017 Jul; 41(6):551-558. PubMed ID: 28637216
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of drug screening in forensic autopsy: retrospective investigation of routine toxicological findings.
    Tominaga M; Michiue T; Inamori-Kawamoto O; Hishmat AM; Oritani S; Takama M; Ishikawa T; Maeda H
    Leg Med (Tokyo); 2015 May; 17(3):172-6. PubMed ID: 25637163
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A case of cannabinoid hyperemesis syndrome caused by synthetic cannabinoids.
    Hopkins CY; Gilchrist BL
    J Emerg Med; 2013 Oct; 45(4):544-6. PubMed ID: 23890687
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rapid identification of synthetic cannabinoids in herbal samples via direct analysis in real time mass spectrometry.
    Musah RA; Domin MA; Walling MA; Shepard JR
    Rapid Commun Mass Spectrom; 2012 May; 26(9):1109-14. PubMed ID: 22467461
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA.
    Hermanns-Clausen M; Müller D; Kithinji J; Angerer V; Franz F; Eyer F; Neurath H; Liebetrau G; Auwärter V
    Clin Toxicol (Phila); 2018 Jun; 56(6):404-411. PubMed ID: 29072524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.